RET and metastatic neoplasm: This subgroup of patients caught our attention due to the early age of presentation, lack of a germline RET variant and high frequency of local and distant metastatic disease (94% and 68.4%, respectively), similar to our cohort of patients with MEN2B (100% and 72.2%; P = .48 and P = .85, respectively).